Cowen & Co. analyst Vivien Azer maintained a Hold rating on Aurora Cannabis (ACB – Research Report) today and set a price target of C$2.00. The company’s shares closed last Tuesday at $1.52, close to its 52-week low of $1.21.
According to TipRanks.com, Azer is a 5-star analyst with an average return of 14.8% and a 58.9% success rate. Azer covers the Consumer Goods sector, focusing on stocks such as Turning Point Brands, Monster Beverage, and Molson Coors.
The word on The Street in general, suggests a Hold analyst consensus rating for Aurora Cannabis with a $2.58 average price target.
Aurora Cannabis’ market cap is currently $328.6M and has a P/E ratio of -0.31.
Based on the recent corporate insider activity of 16 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of ACB in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Aurora Cannabis, Inc. engages in the production, distribution and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.
Read More on ACB:
- Cowen & Co. Reaffirms Their Buy Rating on Canopy Growth (CGC)
- PrairieSky Royalty (PREKF) Received its Third Buy in a Row
- Raymond James Thinks Ivanhoe Mines’ Stock is Going to Recover
- Raymond James Reaffirms Their Hold Rating on Lundin Mining (LUNMF)
- Raymond James Sticks to Their Buy Rating for Teck Resources (TECK)